John M. Flexner

2.4k total citations
45 papers, 1.9k citations indexed

About

John M. Flexner is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, John M. Flexner has authored 45 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 16 papers in Oncology and 14 papers in Genetics. Recurrent topics in John M. Flexner's work include Lymphoma Diagnosis and Treatment (22 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Viral-associated cancers and disorders (10 papers). John M. Flexner is often cited by papers focused on Lymphoma Diagnosis and Treatment (22 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Viral-associated cancers and disorders (10 papers). John M. Flexner collaborates with scholars based in United States. John M. Flexner's co-authors include Robert D. Collins, Richard S. Stein, Alan D. Glick, James H. Leech, James A. Waldron, John B. Cousar, J P Greer, John P. Greer, Robert C. Hartmann and John D. Hainsworth and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

John M. Flexner

44 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John M. Flexner United States 25 1.1k 643 480 443 329 45 1.9k
CW Berard United States 22 1.2k 1.1× 672 1.0× 428 0.9× 266 0.6× 83 0.3× 34 1.7k
Thomas Relander Sweden 21 1.1k 1.0× 754 1.2× 281 0.6× 549 1.2× 327 1.0× 58 1.7k
Andrew J. Fishleder United States 19 426 0.4× 328 0.5× 315 0.7× 235 0.5× 61 0.2× 50 1.3k
Wilhelm Woessmann Germany 26 1.2k 1.1× 740 1.2× 314 0.7× 359 0.8× 117 0.4× 65 2.0k
Dai Chihara United States 25 1.2k 1.1× 932 1.4× 662 1.4× 477 1.1× 119 0.4× 128 2.1k
Dennis P. O’Malley United States 25 654 0.6× 552 0.9× 467 1.0× 242 0.5× 109 0.3× 92 1.9k
J. M. A. Whitehouse United Kingdom 24 553 0.5× 667 1.0× 327 0.7× 239 0.5× 30 0.1× 71 1.8k
Eugènia Abella Spain 21 644 0.6× 497 0.8× 554 1.2× 210 0.5× 60 0.2× 68 1.5k
Jean Gabarre France 31 2.4k 2.2× 2.2k 3.5× 694 1.4× 429 1.0× 165 0.5× 81 3.3k
P L Duffey United States 21 1.6k 1.5× 1.1k 1.7× 584 1.2× 683 1.5× 45 0.1× 30 2.8k

Countries citing papers authored by John M. Flexner

Since Specialization
Citations

This map shows the geographic impact of John M. Flexner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Flexner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Flexner more than expected).

Fields of papers citing papers by John M. Flexner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Flexner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Flexner. The network helps show where John M. Flexner may publish in the future.

Co-authorship network of co-authors of John M. Flexner

This figure shows the co-authorship network connecting the top 25 collaborators of John M. Flexner. A scholar is included among the top collaborators of John M. Flexner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Flexner. John M. Flexner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arrowsmith, Edward, William R. Macon, Marsha C. Kinney, et al.. (2002). Peripheral T-cell Lymphomas: Clinical Features and Prognostic Factors of 92 Cases Defined by the Revised European American Lymphoma Classification. Leukemia & lymphoma. 44(2). 241–249. 53 indexed citations
2.
3.
Stein, Richard S., John P. Greer, John M. Flexner, Stacey Goodman, & Steven N. Wolff. (1996). Etoposide and Mitoxantrone as a Second Cycle of Consolidation Therapy Following High Dose Cytosine Arabinoside and Daunorubicin in Patients with Acute Non-Lymphocytic Leukemia in Remission: A Pilot Study. Leukemia & lymphoma. 23(1-2). 93–98. 1 indexed citations
4.
Greer, John P., William R. Macon, S N Wolff, et al.. (1995). T-cell-rich B-cell lymphomas: diagnosis and response to therapy of 44 patients.. Journal of Clinical Oncology. 13(7). 1742–1750. 50 indexed citations
5.
Stein, Richard S., Robert T. Means, Sanford B. Krantz, John M. Flexner, & John P. Greer. (1994). Treatment of Aplastic Anemia With an Investigational Antilymphocyte Serum Prepared in Rabbits. The American Journal of the Medical Sciences. 308(6). 338–343. 6 indexed citations
6.
Greer, J P, Marsha C. Kinney, Robert D. Collins, et al.. (1991). Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma.. Journal of Clinical Oncology. 9(4). 539–547. 174 indexed citations
7.
McMaster, Mary L., John P. Greer, Steven N. Wolff, et al.. (1991). Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-hodgkin's lymphoma. Cancer. 68(2). 233–241. 18 indexed citations
8.
Stein, R S, J P Greer, John M. Flexner, et al.. (1990). Large-cell lymphomas: clinical and prognostic features.. Journal of Clinical Oncology. 8(8). 1370–1379. 28 indexed citations
9.
Greer, John P., Kevin E. Salhany, John B. Cousar, et al.. (1990). Clinical features associated with transformation of cerebriform T‐cell lymphoma to a large cell process. Hematological Oncology. 8(4). 215–227. 58 indexed citations
10.
Stein, Richard S., John P. Greer, John B. Cousar, et al.. (1989). Malignant lymphomas of follicular centre cell origin in man. VII. Prognostic features in small cleaved cell lymphoma. Hematological Oncology. 7(5). 381–391. 3 indexed citations
11.
Wolff, Steven N., RH Herzig, JW Fay, et al.. (1989). High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and results.. Journal of Clinical Oncology. 7(9). 1260–1267. 124 indexed citations
12.
List, Alan F., J P Greer, Richard S. Stein, et al.. (1988). Non-Hodgkin's lymphoma of the gastrointestinal tract: an analysis of clinical and pathologic features affecting outcome.. Journal of Clinical Oncology. 6(7). 1125–1133. 72 indexed citations
13.
Means, Robert T., Sanford B. Krantz, Emmanuel N. Dessypris, et al.. (1988). Re-treatment of aplastic anemia with antithymocyte globulin or antilymphocyte serum. The American Journal of Medicine. 84(4). 678–682. 16 indexed citations
14.
15.
Stein, Richard S., et al.. (1982). Clinical value of empirical amphotericin B in patients with acute myelogenous leukemia. Cancer. 50(11). 2247–2251. 64 indexed citations
16.
Barton, Dávid, et al.. (1980). Teaching about Dying and Death in a Multidisciplinary Student Group. OMEGA - Journal of Death and Dying. 10(3). 265–270. 9 indexed citations
17.
Stein, Richard S., John M. Flexner, Stanley E. Gräber, et al.. (1979). Malignant lymphomas of follicular center cell origin in man.III. Prognostic Features. Cancer. 44(6). 2236–2243. 42 indexed citations
18.
Waldron, James A., James H. Leech, Alan D. Glick, John M. Flexner, & Robert D. Collins. (1977). Malignant lymphoma of peripheral T-lymphocyte origin.Immunologic, pathologic, and clinical features in six patients. Cancer. 40(4). 1604–1617. 224 indexed citations
19.
Leech, James H., Alan D. Glick, James A. Waldron, et al.. (1975). Malignant Lymphomas of Follicular Center Cell Origin in Man. II. Immunologic Studies23. JNCI Journal of the National Cancer Institute. 54(1). 23–36. 38 indexed citations
20.
Engel, Eric, et al.. (1964). Blood and Skin Chromosomal Alterations of a Clonal Type in a Leukemic Man Previously Irradiated for a Lung Carcinoma. Cytogenetic and Genome Research. 3(4). 228–251. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by CW Berard Breakdown of academic impact, for papers by Thomas Relander Breakdown of academic impact, for papers by Andrew J. Fishleder Breakdown of academic impact, for papers by Wilhelm Woessmann Breakdown of academic impact, for papers by Dai Chihara Breakdown of academic impact, for papers by Dennis P. O’Malley Breakdown of academic impact, for papers by J. M. A. Whitehouse Breakdown of academic impact, for papers by Eugènia Abella Breakdown of academic impact, for papers by Jean Gabarre Breakdown of academic impact, for papers by P L Duffey
Rankless by CCL
2026